AuntMinnie

FEBRUARY 24, 2025

An open-source AI tool can help predict renal function decline in prostate cancer patients undergoing lutetium-177 (Lu-177) radiopharmaceutical therapy, according to a study published February 25 in Radiology. The full study is available here.

Radiopharmaceuticals 291

Radiopharmaceuticals Disease Clinic Radiation 291

Imaging Technology

OCTOBER 17, 2023

a clinical stage radiopharmaceutical company focused on the discovery and development of novel agents for the treatment of a wide range of oncology indications, is pleased to announce that the first subject has been dosed in its Phase 1 study of 68Ga-R8760. milla1cf Tue, 10/17/2023 - 13:07 October 17, 2023 — Radionetics Oncology, Inc.,

Radiopharmaceuticals 116

Radiopharmaceuticals Clinic Disease Diagnose 116

AuntMinnie

JANUARY 19, 2024

more than 6 million Americans have Alzheimer's disease, a debilitating and far-reaching disease that accounts for 60% to 80% of dementia cases, and by 2050, this number is projected to rise to nearly 13 million, according to Alzheimer’s Disease International. The disease affects memory, thinking, and behavior. In the U.S.,

Disease 130

Disease Medicare Imaging PET Scan 130

AuntMinnie

AUGUST 12, 2024

SPECT/CT imaging can help manage patients undergoing radiopharmaceutical therapy (RPT) with Pluvicto for advanced prostate cancer, according to a study published August 8 in the Journal of Nuclear Medicine. Yet whether SPECT/CT can be used to determine disease progression or response has yet to be delineated, they noted.

Nuclear Medicine 260

Nuclear Medicine Bone Scan Disease Radiopharmaceuticals 260

AuntMinnie

MARCH 25, 2024

Coronary artery disease (CAD) is the leading cause of mortality in the U.S. In a cohort of 1,282 patients who underwent invasive coronary angiography for suspected disease, noninvasive PET MPI performed within six months identified large perfusion defects (>10% of the left ventricular myocardium) in 82% of the patients.

Nuclear Medicine 321

Nuclear Medicine Radiopharmaceuticals Disease Imaging 321

AuntMinnie

FEBRUARY 19, 2025

Food and Drug Administration (FDA) for its copper-67 (Cu-67) SAR-bisPSMA radiopharmaceutical for treating advanced prostate cancer. The classification builds on Clarity's earlier receipt of fast-track designation for its PET diagnostic imaging agent Cu-64 SAR-bisPSMA for identifying patients with the disease.

Radiopharmaceuticals 130

Radiopharmaceuticals Pharmaceutical Disease Diagnostic Imaging 130

AuntMinnie

JUNE 9, 2024

Her research also contributed to FDA approval of Lu-177 DOTATATE for treating neuroendocrine tumors; recently, she and collaborators developed a PET imaging agent for vaso-occlusive crisis in sickle cell disease, which has been approved for human studies by the FDA as an Investigational New Drug (IND).

Nuclear Medicine 246

Nuclear Medicine Radiopharmaceuticals Disease Imaging 246

AuntMinnie

JUNE 3, 2024

With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.

Nuclear Medicine 264

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 264

AuntMinnie

FEBRUARY 12, 2024

Chinese clinicians have provided evidence in a “real-world study” that shows amyloid PET imaging is effective for diagnosing and managing patients with Alzheimer’s disease, according to a study published February 8 in Alzheimer’s and Dementia. of patients, noted lead author Ke-Liang Chen, MD, a neurologist at Fudan University.

PET Scan 262

PET Scan Diagnose Disease Radiopharmaceuticals 262

Imaging Technology

JANUARY 5, 2024

This leading radiopharmaceutical platform provides detailed PET imaging-based diagnosis and dosimetry using long-lived copper-64 ( 64 Cu) for imaging and alpha-particle targeted RPT using lead-212 ( 212 Pb). milla1cf Fri, 01/05/2024 - 11:21 January 5, 2024 — Perspective Therapeutics, Inc.

Radiopharmaceuticals 104

Radiopharmaceuticals Clinic Nuclear Medicine Radiation 104

Imaging Technology

JULY 25, 2023

By leveraging our expertise in radiopharmaceuticals, we aim to contribute to the early detection and accurate monitoring of epithelial-derived cancers. This further strengthens our commitment to production and development of novel radiopharmaceuticals to advance cancer treatments and quality of life for cancer patients."

Radiopharmaceuticals 98

Radiopharmaceuticals Imaging Pharmaceutical Diagnostic 98

AuntMinnie

SEPTEMBER 25, 2024

Centers for Medicare and Medicaid Services (CMS) to “unbundle” payments for diagnostic radiopharmaceuticals from the cost of nuclear medicine tests, cardiac SPECT procedures may get the short end of the stick, said Lawrence Phillips, MD, of NYU Langone Health in New York City, in an interview with AuntMinnie.com.

Radiopharmaceuticals 162

Radiopharmaceuticals Nuclear Medicine Medicare Diagnostic 162

Imaging Technology

JULY 11, 2023

By leveraging our expertise in radiopharmaceuticals, we aim to contribute to the early detection and accurate monitoring of epithelial-derived cancers. This partnership exemplifies our commitment to Find, Fight and Follow disease by delivering innovative solutions to improve cancer care, ultimately leading to better patient outcomes."

Radiopharmaceuticals 75

Radiopharmaceuticals Imaging Pharmaceutical Diagnostic 75

Open Medscience

NOVEMBER 16, 2023

In Brazil, the growing radiopharmaceutical market, driven by chronic disease and advanced imaging technologies, is becoming increasingly significant in healthcare. The post Advancing Healthcare: The Dynamic Growth of Brazil’s Radiopharmaceutical Market appeared first on Open Medscience.

Radiopharmaceuticals 59

Radiopharmaceuticals Healthcare Healthcare Disease 59

AuntMinnie

JANUARY 30, 2024

The timing of the new codes dovetails with advances in neuroimaging, such as in the assessment of white-matter diseases. A widely used class of radiopharmaceuticals in the study of the neuroinflammatory response targets the translocator protein (TSPO), according to the researchers.

MRI 263

MRI Radiopharmaceuticals Disease Imaging 263

Open Medscience

AUGUST 11, 2024

Radiopharmaceuticals in diagnostics provide critical insights into disease processes, improving accuracy, patient care, and treatment outcomes significantly. The post The Transformative Power of Radiopharmaceuticals in Diagnostics appeared first on Open MedScience.

Radiopharmaceuticals 52

Radiopharmaceuticals Diagnostic Patient Care Disease 52

AuntMinnie

AUGUST 22, 2024

Food and Drug Administration (FDA) has granted Clarity Pharmaceuticals fast-track designation for its copper-64 (Cu-64) sarcophagine (SAR) bisPSMA radiopharmaceutical.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals Disease Clinic 130

AuntMinnie

JULY 10, 2024

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

Medicare 130

Medicare Nuclear Medicine Radiopharmaceuticals Imaging 130

Open Medscience

FEBRUARY 28, 2024

Exploring the evolving role of radiopharmaceutical diagnostics in enhancing disease detection and personalising treatment in modern medicine. The post Radiopharmaceutical Diagnostics and Imaging Technologies appeared first on Open Medscience.

Radiopharmaceuticals 52

Radiopharmaceuticals Diagnostic Imaging Disease 52

AuntMinnie

AUGUST 2, 2024

CereMark Pharma, a radiopharmaceutical company focused on neurodegenerative diseases, is planning a phase III clinical trial later this year to investigate the novel PET imaging agent F-18 flornaptitril.

Radiopharmaceuticals 130

Radiopharmaceuticals Disease Clinic IT 130

Open Medscience

MARCH 22, 2024

Nuclear medicine and the future of precise, personalised care in diagnosing and treating diseases. The post Nuclear Medicine at the Centre of Radiology and Radiopharmaceuticals appeared first on Open Medscience.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiology Disease 52

AuntMinnie

FEBRUARY 26, 2025

It can detect progressive disease in cases missed by other modalities, demonstrating its potential to guide treatment decisions effectively," they noted. SPECT and low-dose CT scans could be added for areas with suspected radiopharmaceutical uptake. For bone scans, radiopharmaceutical injections averaged 693.87 67.32

Bone Scan 130

Bone Scan Radiopharmaceuticals Imaging Modalities Bone Scintigraphy 130

AuntMinnie

JUNE 10, 2024

The approach may also assist in the early management of patients with advanced, end-stage disease by identifying appropriate treatment regimens and predicting response to therapies, such as radiopharmaceutical therapy.” Automatic cancer detection and characterization can make way for early treatment and better patient outcomes.

Nuclear Medicine 257

Nuclear Medicine Radiopharmaceuticals Imaging Medical Imaging 257

Open Medscience

AUGUST 9, 2024

Radiopharmacy combines the disciplines of pharmacy and nuclear science to create radiopharmaceuticals, revolutionising the diagnosis and treatment of diseases. The post Radiopharmacy: Harnessing Radioactive Compounds for Diagnosis and Treatment appeared first on Open MedScience.

Radiopharmaceuticals 88

Radiopharmaceuticals Disease 88

Imaging Technology

NOVEMBER 7, 2024

Under the new policy, CMS will unpackage and pay separately for diagnostic radiopharmaceuticals with per-day costs exceeding $630, removing financial barriers that have long hindered patient access to essential nuclear medicine diagnostic procedures. tim.hodson Thu, 11/07/2024 - 11:25 Nov.

Nuclear Medicine 97

Nuclear Medicine Radiopharmaceuticals Medicare Diagnostic 97

AuntMinnie

OCTOBER 25, 2024

His research interests include using structural and functional MRI -- particularly ultrahigh-field, 7-tesla MRI -- to map brain microstructure and develop neurosurgical treatment of brain tumors, epilepsy, and neurodegenerative and movement disorders such as Parkinson's disease, essential tremor, and dystonia.

Nuclear Medicine 358

Nuclear Medicine Education Radiology Technologist Radiation Science 358

AuntMinnie

AUGUST 20, 2024

Life Molecular Imaging and PharmaLogic Holdings have inked a partnership and licensing agreement to provide and distribute the imaging agent Neuraceq from PharmaLogic's radiopharmaceutical manufacturing site near Denver, CO. Neuraceq is a diagnostic agent cleared by the U.S. Food and Drug Administration (FDA) for PET imaging of the brain.

Radiopharmaceuticals 100

Radiopharmaceuticals Disease Diagnostic Clinic 100

Imaging Technology

APRIL 5, 2024

milla1cf Fri, 04/05/2024 - 11:31 April 5, 2024 — RLS Radiopharmacies , America’s only Joint Commission-accredited radiopharmacy network, today announced it has expanded its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by entering into a strategic agreement with global isotope technology leader Eckert & Ziegler.

Radiopharmaceuticals 52

Radiopharmaceuticals Radiation Oncology Radiation Quality and Compliance 52

AuntMinnie

OCTOBER 2, 2024

Ultrasound model predicts liver disease progression. Commercially Available Chest Radiograph AI Tools for Detecting Airspace Disease, Pneumothorax, and Pleural Effusion. Increased Metabolic Activity of the Thymus and Lymph Nodes in Pediatric Oncology Patients After Coronavirus Disease 2019 Vaccination.

Digital Imaging and Communications in Medicine 360

Digital Imaging and Communications in Medicine X-ray MRI Hospital 360

Imaging Technology

MAY 14, 2024

Siemens Healthineers and UH will look to also advance the treatment of patients with Alzheimer’s disease and use theranostics—combining the approaches of diagnostics and therapeutics—to treat patients with advanced forms of certain cancers, as well as develop new magnetic resonance ( MR ) technologies. tesla and 3T scanners.

Hospital 116

Hospital Magnetic Resonance Imaging Radiopharmaceuticals Disease 116

Imaging Technology

JUNE 10, 2024

More recently, she and her collaborators developed a PET imaging agent for vaso-occlusive crisis in sickle cell disease, recently approved for human studies by the FDA as an Investigational New Drug. Louis , Missouri, where she worked more than 20 years developing PET and radiopharmaceutical therapy agents.

Nuclear Medicine 104

Nuclear Medicine Radiopharmaceuticals Disease Imaging 104

Imaging Technology

OCTOBER 21, 2024

21, 2024 — Siemens Healthineers recently received Food and Drug Administration clearance for two new features in its syngo.PET Cortical Analysis software application that use positron emission tomography (PET) to measure protein deposits in the brain associated with Alzheimer’s disease. tim.hodson Mon, 10/21/2024 - 10:17 Oct.

Disease 52

Disease Radiopharmaceuticals PET Scan Clinic 52

Imaging Technology

APRIL 28, 2023

Molecular imaging enables doctors and clinicians to see inside the body with a non-invasive process, helping to diagnose and treat diseases such as cancer, cardiovascular disease , and neurological diseases. It uses biomarkers to highlight molecular changes, which can sometimes alert doctors to possible disease.

Healthcare 98

Healthcare Healthcare Radiopharmaceuticals PET Scan 98

AuntMinnie

JULY 29, 2024

In addition, the proposal includes a nuclear health center for processing medical isotopes produced by the reactor into radiochemicals, which will then be further processed into radiopharmaceuticals that can be administered to patients for the diagnosis and treatment of several diseases, including cancer, the commission said.

Medical 130

Medical Nuclear Medicine Radiopharmaceuticals Disease 130

Imaging Technology

APRIL 3, 2023

Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

Imaging Technology

AUGUST 29, 2023

Alan Taylor , stated, “Large-scale manufacture of therapeutic Cu-67 from highly efficient, environmentally preferable electron accelerators is critical to overcome the widespread supply issues in the radiopharmaceutical industry, due to a heavy reliance on a small number of antiquated nuclear reactors.

Pharmaceutical 97

Pharmaceutical Radiopharmaceuticals Clinic Medical 97

Imaging Technology

AUGUST 31, 2023

milla1cf Thu, 08/31/2023 - 15:50 August 31, 2023 — NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals, and Curadh MTR Inc. Ac-225 for use in radiopharmaceutical therapy (RPT). actinium-225 (Ac-225). “As a company at the forefront of U.S.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98